A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)

I6M-MC-SSAD -

The main purpose of this study is to learn more about the safety and side effects of the study drug known as LY3090106 in participants with Sjögren's Syndrome (SS). The study will also evaluate how much of the study drug gets into the blood stream and how long it takes the body to remove it.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Sjögren's Syndrome
What the trial is testing?
LY3090106
Could I receive a Placebo?
Yes
Enrollment Goal
32
Trial Dates
Dec 10, 2015 - Sep 5, 2018
How long will I be in the trial?
Your participation could last up to 28 weeks and include 10 visits to the study center.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.